Clinical Trial Update: Administration of Donor MultiTAA-Specific T Cells for ALL [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating donor multi-TAA-specific T cells for acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Donor MultiTAA-Specific T Cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: Leukemia, Lymphoblastic (Acute) | Phase 1 | Status: COMPLETED